These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31011383)

  • 21. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa.
    Jaquet A; Wandeler G; Tine J; Dagnra CA; Attia A; Patassi A; Ndiaye A; de Ledinghen V; Ekouevi DK; Seydi M; Dabis F
    BMC Infect Dis; 2016 Jun; 16():249. PubMed ID: 27267370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the natural history of chronic hepatitis B].
    Wu G; Zhou W; Zhao Y; Guo S; Wang Z; Zou S; Zhang Q; Ren H; Huang A; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):46-8. PubMed ID: 11856503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease.
    Stroffolini T; Esvan R; Biliotti E; Sagnelli E; Gaeta GB; Almasio PL
    J Med Virol; 2015 Nov; 87(11):1899-903. PubMed ID: 26037919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.
    Hung CH; Wang JH; Lu SN; Hu TH; Lee CM; Chen CH
    J Viral Hepat; 2017 Jul; 24(7):599-607. PubMed ID: 28130815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seroprevalence of HBsAgs in patients with rheumatoid arthiritis in a hospital setting in Senegal].
    Ndongo S; Pouye A; Dia D; Mbaye NM; Lekpa FK; Ndiaye N; Ka MM; Diop TM
    Med Trop (Mars); 2011 Dec; 71(6):632-3. PubMed ID: 22393641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
    Buti M; Fung S; Gane E; Afdhal NH; Flisiak R; Gurel S; Flaherty JF; Martins EB; Yee LJ; Dinh P; Bornstein JD; Mani Subramanian G; Janssen HL; George J; Marcellin P
    Hepatol Int; 2015 Apr; 9(2):243-50. PubMed ID: 25788199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
    Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
    J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in viral hepatitis B screening practices over time in West African HIV clinics.
    Coffie PA; Patassi A; Doumbia A; Bado G; Messou E; Minga A; Allah-Kouadio E; Zannou DM; Seydi M; Kakou AR; Dabis F; Wandeler G
    Med Mal Infect; 2017 Oct; 47(6):394-400. PubMed ID: 28545675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C.
    Yan T; Li K; Li F; Su H; Mu J; Tong S; Patel M; Xia J; Wands JR; Wang H
    J Med Virol; 2011 Jun; 83(6):996-1004. PubMed ID: 21503912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAJOR RISK FACTORS, CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA; A RETROSPECTIVE STUDY AT TIKUR ANBASSA HOSPITAL, ADDIS ABABA UNIVERSITY, ADDIS ABABA, ETHIOPIA.
    Mekonnen HD; Sharma S; Shewaye A; Feld J; Lulu E
    Ethiop Med J; 2015 Jul; 53(3):127-32. PubMed ID: 26677522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
    Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
    BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives and control of hepatitis B virus infection in Taiwan.
    Lin CL; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.